[{"Assets_0_Q2_USD":2691500000.0,"CommonStockSharesOutstanding_0_Q2_shares":43436076.0,"EarningsPerShareBasic_1_Q2_USD":-1.25,"EarningsPerShareBasic_2_Q2_USD":2.74,"EarningsPerShareDiluted_1_Q2_USD":-1.25,"EarningsPerShareDiluted_2_Q2_USD":2.68,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":301500000.0,"StockholdersEquity_0_Q2_USD":1776100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":44900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":45700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":44900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":44700000.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170727"}]